Targeting adenylate-forming enzymes with designed sulfonyladenosine inhibitors

Michaelyn C. Lux(Memorial Sloan Kettering Cancer Center), Lisa C. Standke(Memorial Sloan Kettering Cancer Center), Derek S. Tan(Memorial Sloan Kettering Cancer Center)
The Journal of Antibiotics
April 15, 2019
Cited by 49Open Access
Full Text

Abstract

Adenylate-forming enzymes are a mechanistic superfamily that are involved in diverse biochemical pathways. They catalyze ATP-dependent activation of carboxylic acid substrates as reactive acyl adenylate (acyl-AMP) intermediates and subsequent coupling to various nucleophiles to generate ester, thioester, and amide products. Inspired by natural products, acyl sulfonyladenosines (acyl-AMS) that mimic the tightly bound acyl-AMP reaction intermediates have been developed as potent inhibitors of adenylate-forming enzymes. This simple yet powerful inhibitor design platform has provided a wide range of biological probes as well as several therapeutic lead compounds. Herein, we provide an overview of the nine structural classes of adenylate-forming enzymes and examples of acyl-AMS inhibitors that have been developed for each.


Related Papers

No related papers found

Powered by citation graph analysis